Free Trial
OTCMKTS:CRXTQ

Clarus Therapeutics (CRXTQ) Stock Price, News & Analysis

Clarus Therapeutics logo
$0.0010 0.00 (0.00%)
As of 03/6/2023

About Clarus Therapeutics Stock (OTCMKTS:CRXTQ)

Key Stats

Today's Range
$0.0010
$0.0010
50-Day Range
N/A
52-Week Range
$0.00
$3.94
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRXTQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clarus Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRXTQ Stock News Headlines

Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Clarus Therapeutics Holdings Inc.
Clarus Therapeutics Holdings, Inc. (CRXT)
See More Headlines

CRXTQ Stock Analysis - Frequently Asked Questions

Clarus Therapeutics' stock was trading at $0.0010 on January 1st, 2025. Since then, CRXTQ stock has increased by 0.0% and is now trading at $0.0010.

Clarus Therapeutics Holdings, Inc. (OTCMKTS:CRXTQ) issued its quarterly earnings data on Thursday, November, 18th. The company reported ($0.26) EPS for the quarter, topping analysts' consensus estimates of ($0.81) by $0.55. The company earned $4.29 million during the quarter, compared to analyst estimates of $3.30 million.

Shares of CRXTQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/18/2021
Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:CRXTQ
CIK
1817944
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:CRXTQ) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners